Global Wilson's Disease Treatment
Global Wilson's Disease Treatment

Wilson's Disease Treatment Comprehensive Study by Type (Medication (Trientine, Penicillamine, Zinc Acatate), Surgery), Application (Hospitals, Specialty Clinics, Diagnostic Laboratories), Test Type (Blood and Urine Test, Eye Exam, Biopsy, Genetic Testing), Symptoms (Fatigue, Fluid in Belly or Legs, Easy Bruising, Swollen Liver and Spleen, Stiff Muscles, Difficulty in Swallowing, Psychological Changes, Anemia, Others) Players and Region - Global Market Outlook to 2026

Wilson's Disease Treatment Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jan 2021 Edition 246 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Wilson's Disease Treatment Market Scope?
Wilson's disease is a genetic disorder caused by the loss of function of the copper-binding ATP7B protein, which leads to impairment of copper transport and excretion. This leads to an accumulation of free copper in the bloodstream, which leads to damage to the liver, brain, and other organs. Because Wilson's disease is difficult to distinguish from other serious hepatic or neurological disorders that result in fewer patients being diagnosed than the actual prevalence of Wilson's disease. Wilson disease is characterized by the degree of free copper accumulation in the liver and brain. While patients with Wilson's disease may either be asymptomatic or have one or more clinical symptoms that may vary in type and severity, including liver disease, neurological manifestations, and psychiatric disorders. Symptoms of Wilson's disease can include abdominal pain, loss of appetite, fatigue, jaundice, problems with language, swallowing, or physical coordination, and uncontrolled movements or muscle stiffness. Wilson disease is suspected in people ages 3 to 60, while the chance that a child will inherit the autosomal recessive mutation from both parents by gene mutation is 25% or one of four ratios.

The Wilson's Disease Treatment market study is being classified by Type (Medication [Trientine, Penicillamine, Zinc Acatate] and Surgery), by Application (Hospitals, Specialty Clinics and Diagnostic Laboratories) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Wilson's Disease Treatment market throughout the predicted period.

Valeant Pharmaceuticals International Inc. (United States), Tsumura & Co (Japan), Kadmon Holdings, Inc. (United States), Merck & Co. (United States), Bausch Health Companies Inc. (United States), VHB Life Science Inc. (India), Teva Pharmaceuticals USA, Inc. (United States), Wilson's Therapeutics AB (Sweden), Noble Pharma Co., Ltd (Japan), Granules India Limited (India) and Wilson Drugs and Pharmaceuticals Private Limited (India) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Wilson's Disease Treatment market by Type, Application and Region.

On the basis of geography, the market of Wilson's Disease Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

On December 3, 2020, Granules India announced that the U.S. Food & Drug Administration (US FDA) had approved the Abbreviated New Drug Application (ANDA ) has approved USP, 250 mg. It is bioequivalent to the drug (RLD) Cuprimine from Bausch Health Americas listed in the reference list. The product is manufactured at the Chantilly, Virginia, granules facility and is expected to be launched shortly. Penicillamine capsules are hereby used for the treatment of Wilson's disease and cystinuria.


Influencing Market Trend
  • Rising Demand for Rapid Diagnosis and Better Treatment
  • Increasing the Implementation of Patient Assistance Programs
  • Supportive Regulatory Environment Provided by the USFDA for Drugs Employed in Treatment of Wilsonís Disease

Market Drivers
  • Rapid Growth in Aging Population
  • Increase in Healthcare Expenditure
  • An Upsurge in Highly Health Conscious People
  • Increase In Awareness Regarding Wilsonís Disease

Opportunities
  • Rapid Advancements in Technology Allowing For Early Detection
  • Growing Investment by Market Players

Restraints
  • High Treatment Costs Due To Complications

Challenges
  • Less Awareness Regarding the Symptoms of Wilsonís Disease


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Wilson's Disease Treatment, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.
Report Objectives / Segmentation Covered
By Type
  • Medication [Trientine, Penicillamine, Zinc Acatate]
  • Surgery
By Application
  • Hospitals
  • Specialty Clinics
  • Diagnostic Laboratories
By Test Type
  • Blood and Urine Test
  • Eye Exam
  • Biopsy
  • Genetic Testing

By Symptoms
  • Fatigue
  • Fluid in Belly or Legs
  • Easy Bruising
  • Swollen Liver and Spleen
  • Stiff Muscles
  • Difficulty in Swallowing
  • Psychological Changes
  • Anemia
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rapid Growth in Aging Population
      • 3.2.2. Increase in Healthcare Expenditure
      • 3.2.3. An Upsurge in Highly Health Conscious People
      • 3.2.4. Increase In Awareness Regarding Wilsonís Disease
    • 3.3. Market Challenges
      • 3.3.1. Less Awareness Regarding the Symptoms of Wilsonís Disease
    • 3.4. Market Trends
      • 3.4.1. Rising Demand for Rapid Diagnosis and Better Treatment
      • 3.4.2. Increasing the Implementation of Patient Assistance Programs
      • 3.4.3. Supportive Regulatory Environment Provided by the USFDA for Drugs Employed in Treatment of Wilsonís Disease
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Wilson's Disease Treatment, by Type, Application, Test Type, Symptoms and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Wilson's Disease Treatment (Value)
      • 5.2.1. Global Wilson's Disease Treatment by: Type (Value)
        • 5.2.1.1. Medication [Trientine, Penicillamine, Zinc Acatate]
        • 5.2.1.2. Surgery
      • 5.2.2. Global Wilson's Disease Treatment by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Specialty Clinics
        • 5.2.2.3. Diagnostic Laboratories
      • 5.2.3. Global Wilson's Disease Treatment by: Test Type (Value)
        • 5.2.3.1. Blood and Urine Test
        • 5.2.3.2. Eye Exam
        • 5.2.3.3. Biopsy
        • 5.2.3.4. Genetic Testing
      • 5.2.4. Global Wilson's Disease Treatment by: Symptoms (Value)
        • 5.2.4.1. Fatigue
        • 5.2.4.2. Fluid in Belly or Legs
        • 5.2.4.3. Easy Bruising
        • 5.2.4.4. Swollen Liver and Spleen
        • 5.2.4.5. Stiff Muscles
        • 5.2.4.6. Difficulty in Swallowing
        • 5.2.4.7. Psychological Changes
        • 5.2.4.8. Anemia
        • 5.2.4.9. Others
      • 5.2.5. Global Wilson's Disease Treatment Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Wilson's Disease Treatment (Price)
      • 5.3.1. Global Wilson's Disease Treatment by: Type (Price)
  • 6. Wilson's Disease Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Valeant Pharmaceuticals International Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Tsumura & Co (Japan)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Kadmon Holdings, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck & Co. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bausch Health Companies Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. VHB Life Science Inc. (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Teva Pharmaceuticals USA, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Wilson's Therapeutics AB (Sweden)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Noble Pharma Co., Ltd (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Granules India Limited (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Wilson Drugs and Pharmaceuticals Private Limited (India)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Wilson's Disease Treatment Sale, by Type, Application, Test Type, Symptoms and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Wilson's Disease Treatment (Value)
      • 7.2.1. Global Wilson's Disease Treatment by: Type (Value)
        • 7.2.1.1. Medication [Trientine, Penicillamine, Zinc Acatate]
        • 7.2.1.2. Surgery
      • 7.2.2. Global Wilson's Disease Treatment by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Specialty Clinics
        • 7.2.2.3. Diagnostic Laboratories
      • 7.2.3. Global Wilson's Disease Treatment by: Test Type (Value)
        • 7.2.3.1. Blood and Urine Test
        • 7.2.3.2. Eye Exam
        • 7.2.3.3. Biopsy
        • 7.2.3.4. Genetic Testing
      • 7.2.4. Global Wilson's Disease Treatment by: Symptoms (Value)
        • 7.2.4.1. Fatigue
        • 7.2.4.2. Fluid in Belly or Legs
        • 7.2.4.3. Easy Bruising
        • 7.2.4.4. Swollen Liver and Spleen
        • 7.2.4.5. Stiff Muscles
        • 7.2.4.6. Difficulty in Swallowing
        • 7.2.4.7. Psychological Changes
        • 7.2.4.8. Anemia
        • 7.2.4.9. Others
      • 7.2.5. Global Wilson's Disease Treatment Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Wilson's Disease Treatment (Price)
      • 7.3.1. Global Wilson's Disease Treatment by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Wilson's Disease Treatment: by Type(USD Million)
  • Table 2. Wilson's Disease Treatment Medication [Trientine, Penicillamine, Zinc Acatate] , by Region USD Million (2015-2020)
  • Table 3. Wilson's Disease Treatment Surgery , by Region USD Million (2015-2020)
  • Table 4. Wilson's Disease Treatment: by Application(USD Million)
  • Table 5. Wilson's Disease Treatment Hospitals , by Region USD Million (2015-2020)
  • Table 6. Wilson's Disease Treatment Specialty Clinics , by Region USD Million (2015-2020)
  • Table 7. Wilson's Disease Treatment Diagnostic Laboratories , by Region USD Million (2015-2020)
  • Table 8. Wilson's Disease Treatment: by Test Type(USD Million)
  • Table 9. Wilson's Disease Treatment Blood and Urine Test , by Region USD Million (2015-2020)
  • Table 10. Wilson's Disease Treatment Eye Exam , by Region USD Million (2015-2020)
  • Table 11. Wilson's Disease Treatment Biopsy , by Region USD Million (2015-2020)
  • Table 12. Wilson's Disease Treatment Genetic Testing , by Region USD Million (2015-2020)
  • Table 13. Wilson's Disease Treatment: by Symptoms(USD Million)
  • Table 14. Wilson's Disease Treatment Fatigue , by Region USD Million (2015-2020)
  • Table 15. Wilson's Disease Treatment Fluid in Belly or Legs , by Region USD Million (2015-2020)
  • Table 16. Wilson's Disease Treatment Easy Bruising , by Region USD Million (2015-2020)
  • Table 17. Wilson's Disease Treatment Swollen Liver and Spleen , by Region USD Million (2015-2020)
  • Table 18. Wilson's Disease Treatment Stiff Muscles , by Region USD Million (2015-2020)
  • Table 19. Wilson's Disease Treatment Difficulty in Swallowing , by Region USD Million (2015-2020)
  • Table 20. Wilson's Disease Treatment Psychological Changes , by Region USD Million (2015-2020)
  • Table 21. Wilson's Disease Treatment Anemia , by Region USD Million (2015-2020)
  • Table 22. Wilson's Disease Treatment Others , by Region USD Million (2015-2020)
  • Table 23. South America Wilson's Disease Treatment, by Country USD Million (2015-2020)
  • Table 24. South America Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 25. South America Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 26. South America Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 27. South America Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 28. Brazil Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 29. Brazil Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 30. Brazil Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 31. Brazil Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 32. Argentina Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 33. Argentina Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 34. Argentina Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 35. Argentina Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 36. Rest of South America Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 37. Rest of South America Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 38. Rest of South America Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 39. Rest of South America Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 40. Asia Pacific Wilson's Disease Treatment, by Country USD Million (2015-2020)
  • Table 41. Asia Pacific Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 42. Asia Pacific Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 43. Asia Pacific Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 44. Asia Pacific Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 45. China Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 46. China Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 47. China Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 48. China Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 49. Japan Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 50. Japan Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 51. Japan Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 52. Japan Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 53. India Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 54. India Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 55. India Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 56. India Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 57. South Korea Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 58. South Korea Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 59. South Korea Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 60. South Korea Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 61. Taiwan Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 62. Taiwan Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 63. Taiwan Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 64. Taiwan Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 65. Australia Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 66. Australia Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 67. Australia Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 68. Australia Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 70. Rest of Asia-Pacific Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 71. Rest of Asia-Pacific Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 72. Rest of Asia-Pacific Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 73. Europe Wilson's Disease Treatment, by Country USD Million (2015-2020)
  • Table 74. Europe Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 75. Europe Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 76. Europe Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 77. Europe Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 78. Germany Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 79. Germany Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 80. Germany Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 81. Germany Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 82. France Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 83. France Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 84. France Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 85. France Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 86. Italy Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 87. Italy Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 88. Italy Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 89. Italy Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 90. United Kingdom Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 91. United Kingdom Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 92. United Kingdom Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 93. United Kingdom Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 94. Netherlands Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 95. Netherlands Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 96. Netherlands Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 97. Netherlands Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 98. Rest of Europe Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 99. Rest of Europe Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 100. Rest of Europe Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 101. Rest of Europe Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 102. MEA Wilson's Disease Treatment, by Country USD Million (2015-2020)
  • Table 103. MEA Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 104. MEA Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 105. MEA Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 106. MEA Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 107. Middle East Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 108. Middle East Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 109. Middle East Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 110. Middle East Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 111. Africa Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 112. Africa Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 113. Africa Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 114. Africa Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 115. North America Wilson's Disease Treatment, by Country USD Million (2015-2020)
  • Table 116. North America Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 117. North America Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 118. North America Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 119. North America Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 120. United States Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 121. United States Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 122. United States Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 123. United States Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 124. Canada Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 125. Canada Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 126. Canada Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 127. Canada Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 128. Mexico Wilson's Disease Treatment, by Type USD Million (2015-2020)
  • Table 129. Mexico Wilson's Disease Treatment, by Application USD Million (2015-2020)
  • Table 130. Mexico Wilson's Disease Treatment, by Test Type USD Million (2015-2020)
  • Table 131. Mexico Wilson's Disease Treatment, by Symptoms USD Million (2015-2020)
  • Table 132. Wilson's Disease Treatment: by Type(USD/Units)
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Wilson's Disease Treatment: by Type(USD Million)
  • Table 145. Wilson's Disease Treatment Medication [Trientine, Penicillamine, Zinc Acatate] , by Region USD Million (2021-2026)
  • Table 146. Wilson's Disease Treatment Surgery , by Region USD Million (2021-2026)
  • Table 147. Wilson's Disease Treatment: by Application(USD Million)
  • Table 148. Wilson's Disease Treatment Hospitals , by Region USD Million (2021-2026)
  • Table 149. Wilson's Disease Treatment Specialty Clinics , by Region USD Million (2021-2026)
  • Table 150. Wilson's Disease Treatment Diagnostic Laboratories , by Region USD Million (2021-2026)
  • Table 151. Wilson's Disease Treatment: by Test Type(USD Million)
  • Table 152. Wilson's Disease Treatment Blood and Urine Test , by Region USD Million (2021-2026)
  • Table 153. Wilson's Disease Treatment Eye Exam , by Region USD Million (2021-2026)
  • Table 154. Wilson's Disease Treatment Biopsy , by Region USD Million (2021-2026)
  • Table 155. Wilson's Disease Treatment Genetic Testing , by Region USD Million (2021-2026)
  • Table 156. Wilson's Disease Treatment: by Symptoms(USD Million)
  • Table 157. Wilson's Disease Treatment Fatigue , by Region USD Million (2021-2026)
  • Table 158. Wilson's Disease Treatment Fluid in Belly or Legs , by Region USD Million (2021-2026)
  • Table 159. Wilson's Disease Treatment Easy Bruising , by Region USD Million (2021-2026)
  • Table 160. Wilson's Disease Treatment Swollen Liver and Spleen , by Region USD Million (2021-2026)
  • Table 161. Wilson's Disease Treatment Stiff Muscles , by Region USD Million (2021-2026)
  • Table 162. Wilson's Disease Treatment Difficulty in Swallowing , by Region USD Million (2021-2026)
  • Table 163. Wilson's Disease Treatment Psychological Changes , by Region USD Million (2021-2026)
  • Table 164. Wilson's Disease Treatment Anemia , by Region USD Million (2021-2026)
  • Table 165. Wilson's Disease Treatment Others , by Region USD Million (2021-2026)
  • Table 166. South America Wilson's Disease Treatment, by Country USD Million (2021-2026)
  • Table 167. South America Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 168. South America Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 169. South America Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 170. South America Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 171. Brazil Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 172. Brazil Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 173. Brazil Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 174. Brazil Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 175. Argentina Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 176. Argentina Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 177. Argentina Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 178. Argentina Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 179. Rest of South America Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 180. Rest of South America Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 181. Rest of South America Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 182. Rest of South America Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 183. Asia Pacific Wilson's Disease Treatment, by Country USD Million (2021-2026)
  • Table 184. Asia Pacific Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 185. Asia Pacific Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 186. Asia Pacific Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 187. Asia Pacific Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 188. China Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 189. China Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 190. China Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 191. China Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 192. Japan Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 193. Japan Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 194. Japan Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 195. Japan Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 196. India Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 197. India Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 198. India Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 199. India Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 200. South Korea Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 201. South Korea Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 202. South Korea Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 203. South Korea Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 204. Taiwan Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 205. Taiwan Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 206. Taiwan Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 207. Taiwan Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 208. Australia Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 209. Australia Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 210. Australia Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 211. Australia Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 212. Rest of Asia-Pacific Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 213. Rest of Asia-Pacific Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 214. Rest of Asia-Pacific Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 215. Rest of Asia-Pacific Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 216. Europe Wilson's Disease Treatment, by Country USD Million (2021-2026)
  • Table 217. Europe Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 218. Europe Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 219. Europe Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 220. Europe Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 221. Germany Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 222. Germany Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 223. Germany Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 224. Germany Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 225. France Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 226. France Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 227. France Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 228. France Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 229. Italy Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 230. Italy Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 231. Italy Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 232. Italy Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 233. United Kingdom Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 234. United Kingdom Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 235. United Kingdom Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 236. United Kingdom Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 237. Netherlands Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 238. Netherlands Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 239. Netherlands Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 240. Netherlands Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 241. Rest of Europe Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 242. Rest of Europe Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 243. Rest of Europe Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 244. Rest of Europe Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 245. MEA Wilson's Disease Treatment, by Country USD Million (2021-2026)
  • Table 246. MEA Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 247. MEA Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 248. MEA Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 249. MEA Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 250. Middle East Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 251. Middle East Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 252. Middle East Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 253. Middle East Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 254. Africa Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 255. Africa Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 256. Africa Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 257. Africa Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 258. North America Wilson's Disease Treatment, by Country USD Million (2021-2026)
  • Table 259. North America Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 260. North America Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 261. North America Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 262. North America Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 263. United States Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 264. United States Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 265. United States Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 266. United States Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 267. Canada Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 268. Canada Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 269. Canada Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 270. Canada Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 271. Mexico Wilson's Disease Treatment, by Type USD Million (2021-2026)
  • Table 272. Mexico Wilson's Disease Treatment, by Application USD Million (2021-2026)
  • Table 273. Mexico Wilson's Disease Treatment, by Test Type USD Million (2021-2026)
  • Table 274. Mexico Wilson's Disease Treatment, by Symptoms USD Million (2021-2026)
  • Table 275. Wilson's Disease Treatment: by Type(USD/Units)
  • Table 276. Research Programs/Design for This Report
  • Table 277. Key Data Information from Secondary Sources
  • Table 278. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Wilson's Disease Treatment: by Type USD Million (2015-2020)
  • Figure 5. Global Wilson's Disease Treatment: by Application USD Million (2015-2020)
  • Figure 6. Global Wilson's Disease Treatment: by Test Type USD Million (2015-2020)
  • Figure 7. Global Wilson's Disease Treatment: by Symptoms USD Million (2015-2020)
  • Figure 8. South America Wilson's Disease Treatment Share (%), by Country
  • Figure 9. Asia Pacific Wilson's Disease Treatment Share (%), by Country
  • Figure 10. Europe Wilson's Disease Treatment Share (%), by Country
  • Figure 11. MEA Wilson's Disease Treatment Share (%), by Country
  • Figure 12. North America Wilson's Disease Treatment Share (%), by Country
  • Figure 13. Global Wilson's Disease Treatment: by Type USD/Units (2015-2020)
  • Figure 14. Global Wilson's Disease Treatment share by Players 2020 (%)
  • Figure 15. Global Wilson's Disease Treatment share by Players (Top 3) 2020(%)
  • Figure 16. Global Wilson's Disease Treatment share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Valeant Pharmaceuticals International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Valeant Pharmaceuticals International Inc. (United States) Revenue: by Geography 2020
  • Figure 20. Tsumura & Co (Japan) Revenue, Net Income and Gross profit
  • Figure 21. Tsumura & Co (Japan) Revenue: by Geography 2020
  • Figure 22. Kadmon Holdings, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Kadmon Holdings, Inc. (United States) Revenue: by Geography 2020
  • Figure 24. Merck & Co. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Merck & Co. (United States) Revenue: by Geography 2020
  • Figure 26. Bausch Health Companies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Bausch Health Companies Inc. (United States) Revenue: by Geography 2020
  • Figure 28. VHB Life Science Inc. (India) Revenue, Net Income and Gross profit
  • Figure 29. VHB Life Science Inc. (India) Revenue: by Geography 2020
  • Figure 30. Teva Pharmaceuticals USA, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Teva Pharmaceuticals USA, Inc. (United States) Revenue: by Geography 2020
  • Figure 32. Wilson's Therapeutics AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 33. Wilson's Therapeutics AB (Sweden) Revenue: by Geography 2020
  • Figure 34. Noble Pharma Co., Ltd (Japan) Revenue, Net Income and Gross profit
  • Figure 35. Noble Pharma Co., Ltd (Japan) Revenue: by Geography 2020
  • Figure 36. Granules India Limited (India) Revenue, Net Income and Gross profit
  • Figure 37. Granules India Limited (India) Revenue: by Geography 2020
  • Figure 38. Wilson Drugs and Pharmaceuticals Private Limited (India) Revenue, Net Income and Gross profit
  • Figure 39. Wilson Drugs and Pharmaceuticals Private Limited (India) Revenue: by Geography 2020
  • Figure 40. Global Wilson's Disease Treatment: by Type USD Million (2021-2026)
  • Figure 41. Global Wilson's Disease Treatment: by Application USD Million (2021-2026)
  • Figure 42. Global Wilson's Disease Treatment: by Test Type USD Million (2021-2026)
  • Figure 43. Global Wilson's Disease Treatment: by Symptoms USD Million (2021-2026)
  • Figure 44. South America Wilson's Disease Treatment Share (%), by Country
  • Figure 45. Asia Pacific Wilson's Disease Treatment Share (%), by Country
  • Figure 46. Europe Wilson's Disease Treatment Share (%), by Country
  • Figure 47. MEA Wilson's Disease Treatment Share (%), by Country
  • Figure 48. North America Wilson's Disease Treatment Share (%), by Country
  • Figure 49. Global Wilson's Disease Treatment: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Valeant Pharmaceuticals International Inc. (United States)
  • Tsumura & Co (Japan)
  • Kadmon Holdings, Inc. (United States)
  • Merck & Co. (United States)
  • Bausch Health Companies Inc. (United States)
  • VHB Life Science Inc. (India)
  • Teva Pharmaceuticals USA, Inc. (United States)
  • Wilson's Therapeutics AB (Sweden)
  • Noble Pharma Co., Ltd (Japan)
  • Granules India Limited (India)
  • Wilson Drugs and Pharmaceuticals Private Limited (India)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation